CTLA4 and neoplasm: Han et al. demonstrated that thermal ablation of murine flank colorectal tumors followed by administration of toll-like-receptor agonists and anti-CTLA-4 therapies resulted in destruction of tumors at distant sites with a significant increases in their CD8+ T cell to Treg ratio, as well as long-term resistance to tumor re-challenge [117].